SYMBOL:

    Up to 100 tickers separated by a space
Site Map FAQ Contact us Home Personalize
Company
Industry
Earnings
US Markets
Most Active
Portfolio
Tools
ETFs
Ratings
IMPRIMIS PHARMACEUTICALS INC
(NQSC:IMMY Last Sale: 6.13 )
Fundamentals Charts Tech Analysis Industry Earnings
Company Profile   Details

Company Web Site
NQSC: (IMMY : $6.13)
$208 million Market Cap at September 12, 2013
Drugs SubIndustry up .00% / Health Industry up .00% Today

Solana Beach, CA Research Report Earnings Snapshot - Last 11/12/18
Fact Sheet
Financial Statements
Peer Comparison
Annual Reports


lead drug candidate, Impracor, utilizes Accudelâ„¢ cream formulation to deliver ketoprofen, a non-steroidal anti-inflammatory drug (NSAID), to target underlying tissue where Impracor exerts its localized anti-inflammatory effect.
Historical Charts    Technical Analysis
No Historical Data available for IMMY

Type of Stock Symbol Last Sale Last Close Net +/- % +/- Low High Volume 52wk Low 52wk High Shares(M)
Common IMMY $6.13 $ 0 $6.13 $6.38 5,700 $4.6 $75 33,859
Capitalization
Earnings Summary ()
*** No Earnings Available***
-10121
Common Stock $207,556

A
Google



QUICK NAVIGATION SITE SEARCH   Enter Keyword:
   
Home    Subscribe    Browser Help    Subscriber Services    B-to-B    Banks    Brokerage    Telco    Site Map    Legal    Contact/Email
Copyright © 1996 - 2024 Stock Smart with all rights reserved
Feed is currently being brought back up
Provided by Nanex